V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260010206 | 260006425 | null | 73.5 | Not known (9) | 2014-02-16 | 2014-02-16 | 111 Trial (formerly BEP 111) | 2 | N | 260007854 | CISPLATIN + ETOPOSIDE |
| 260010247 | 260006442 | null | null | Curative (C) | null | 2017-08-09 | 111 Trial (formerly BEP 111) | null | null | 260006315 | CARBOPLATIN + ETOPOSIDE |
| 260010221 | 260006431 | 1.9 | 80.7 | Neo-adjuvant (N) | 2018-06-23 | 2018-07-20 | 111 Trial (formerly BEP 111) | N | N | 260015253 | RITUXIMAB |
| 260010211 | 260006427 | 1.67 | 114 | Curative (C) | 2017-11-16 | 2017-12-07 | 111 Trial (formerly BEP 111) | 2 | N | 260009565 | TIP |
| 260009478 | 260006115 | 1.72 | 70.6 | Palliative (P) | 2017-04-16 | 2017-04-27 | 111 Trial (formerly BEP 111) | 02 | N | 260029946 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009518 | 260017458 | null | 75.8 | null | 2017-12-24 | 2018-01-27 | 111 Trial (formerly BEP 111) | 2 | N | 260030043 | CISPLATIN + ETOPOSIDE |
| 260009523 | 260006133 | 1.88 | 63.2 | null | null | 2015-08-23 | 111 Trial (formerly BEP 111) | N | N | 260030055 | CARBOPLATIN + ETOPOSIDE |
| 260009568 | 260006153 | null | 104.2 | Curative (C) | 2013-02-12 | 2013-02-13 | 111 Trial (formerly BEP 111) | null | Y | 260030144 | CARBOPLATIN + ETOPOSIDE |
| 260009569 | 260006154 | 1.8 | 87.4 | Curative (C) | 2016-03-04 | 2016-03-08 | 111 Trial (formerly BEP 111) | N | N | 260030153 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE |
| 260009593 | 260006166 | null | 93.8 | Curative (C) | 2015-05-08 | 2015-05-31 | 111 Trial (formerly BEP 111) | N | N | 260006175 | BRENTUXIMAB |
| 260009651 | 260006192 | 1.8 | null | Palliative (P) | 2013-10-23 | 2013-11-22 | 111 Trial (formerly BEP 111) | null | N | 260007708 | CISPLATIN + ETOPOSIDE |
| 260009685 | 260006207 | 1.76 | 90.7 | null | 2018-05-10 | 2018-05-12 | 111 Trial (formerly BEP 111) | N | N | 260008239 | CISPLATIN + ETOPOSIDE |
| 260009696 | 260006211 | 0 | 76 | Palliative (P) | null | 2019-02-10 | 111 Trial (formerly BEP 111) | N | N | 260008455 | CISPLATIN + ETOPOSIDE |
| 260009718 | 260015686 | null | 78.3 | Palliative (P) | 2016-06-04 | 2016-06-06 | 111 Trial (formerly BEP 111) | N | N | 260008770 | CISPLATIN + ETOPOSIDE |
| 260009810 | 260006262 | null | null | Palliative (P) | 2016-10-06 | 2016-10-29 | 111 Trial (formerly BEP 111) | N | N | 260010297 | PEMBROLIZUMAB |
| 260009847 | 260006277 | 1.81 | null | null | 2018-09-11 | 2018-09-12 | 111 Trial (formerly BEP 111) | 02 | N | 260010651 | DOXORUBICIN |
| 260009999 | 260006344 | null | 76.1 | Curative (C) | 2017-11-22 | 2017-11-28 | 111 Trial (formerly BEP 111) | N | N | 260015253 | TRASTUZUMAB |
| 260010066 | 260006371 | 1.65 | null | Curative (C) | 2018-01-05 | 2018-03-04 | 111 Trial (formerly BEP 111) | 02 | null | 260018409 | BOP |
| 260010114 | 260006389 | null | 107.4 | Palliative (P) | 2015-11-23 | 2015-12-01 | 111 Trial (formerly BEP 111) | N | N | 260021385 | CISPLATIN + ETOPOSIDE |
| 260010118 | 260012482 | 1.81 | 101 | Disease modification (D) | 2015-10-01 | 2015-10-02 | 111 Trial (formerly BEP 111) | 2 | N | 260021620 | CARBOPLATIN + PACLITAXEL |
| 260010123 | 260006391 | 1.72 | 62 | null | null | 2015-07-20 | 111 Trial (formerly BEP 111) | N | N | 260022492 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010149 | 260006399 | 1.98 | 72.2 | null | null | 2016-02-24 | 111 Trial (formerly BEP 111) | null | null | 260026217 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260010150 | 260006400 | 1.64 | 84 | Palliative (P) | 2018-02-10 | 2018-02-13 | 111 Trial (formerly BEP 111) | 02 | N | 260026662 | CISPLATIN + ETOPOSIDE |
| 260010174 | 260006409 | 1.6 | 85.4 | Radical (R) | 2014-07-01 | 2014-07-14 | 111 Trial (formerly BEP 111) | N | N | 260029639 | CISPLATIN + ETOPOSIDE |
| 30010528 | 30006685 | 1.63 | 77.3 | Palliative (P) | 2016-01-08 | 2016-01-08 | A-PREDICT TRIAL | Y | N | 30171070 | TRIAL |
| 90009671 | 90005282 | null | 102.1 | Palliative (P) | 2017-01-31 | 2017-02-11 | A-PREDICT TRIAL | 02 | null | 90036355 | TRIAL |
| 20057487 | 20025216 | 0 | 99.7 | Adjuvant (A) | 2017-01-29 | 2017-01-29 | A-PREDICT TRIAL | 01 | N | 20202205 | TRIAL |
| 30010966 | 30006977 | 1.77 | 104.4 | Curative (C) | 2014-10-24 | 2014-11-05 | A-PREDICT TRIAL | 1 | N | 30178885 | TRIAL |
| 90004061 | 90002176 | null | null | Palliative (P) | 2017-04-06 | 2017-04-06 | A-PREDICT TRIAL | 02 | N | 90032334 | NIVOLUMAB |
| 90004102 | 90002193 | 1.83 | null | Palliative (P) | 2014-07-19 | 2014-07-25 | A-PREDICT TRIAL | 02 | N | 90032650 | RITUXIMAB |
| 90004267 | 90002267 | null | 75.5 | Palliative (P) | 2017-07-19 | 2017-07-19 | A-PREDICT TRIAL | Y | N | 90033881 | AXITINIB |
| 90004325 | 90002296 | 0 | 62 | Palliative (P) | 2015-04-12 | 2015-04-12 | A-PREDICT TRIAL | null | null | 90034367 | STAR TRIAL |
| 90004436 | 90006939 | 0 | 74.6 | Palliative (P) | 2014-01-10 | 2014-01-10 | A-PREDICT TRIAL | 01 | N | 90035256 | FLUOROURACIL + MITOMYCIN |
| 90004595 | 90002430 | 1.73 | 114 | Palliative (P) | 2016-08-04 | 2016-08-25 | A-PREDICT TRIAL | N | N | 90036405 | TRIAL |
| 90004640 | 90009158 | 1.84 | 0 | Not known (9) | null | 2018-01-06 | A-PREDICT TRIAL | N | Y | 90036783 | TRIAL |
| 90004724 | 90002492 | 1.73 | 62.9 | Palliative (P) | 2013-11-29 | 2013-11-29 | A-PREDICT TRIAL | N | N | 90037360 | TRIAL |
| 90004829 | 90002545 | null | null | Palliative (P) | 2014-06-09 | 2014-06-22 | A-PREDICT TRIAL | N | Y | 90038122 | TEMSIROLIMUS |
| 90004878 | 90002566 | 1.6 | 0 | Palliative (P) | 2015-12-11 | 2017-01-31 | A-PREDICT TRIAL | N | null | 90038605 | NIVOLUMAB |
| 90004919 | 90002586 | 1.52 | 101.7 | Palliative (P) | 2017-01-02 | 2018-03-06 | A-PREDICT TRIAL | 01 | N | 90038927 | BEVACIZUMAB + CAPECITABINE |
| 90004958 | 90002608 | 1.83 | null | Curative (C) | 2016-02-06 | 2016-03-10 | A-PREDICT TRIAL | N | N | 90039266 | TRIAL |
| 90005083 | 90002662 | null | 58.2 | Palliative (P) | 2013-05-20 | 2013-05-20 | A-PREDICT TRIAL | 02 | N | 90040255 | TRIAL |
| 90005119 | 90002679 | 1.59 | null | null | null | 2016-07-21 | A-PREDICT TRIAL | N | 0 | 90040525 | STAR TRIAL |
| 90005250 | 90002740 | 1.24 | 87.99 | Palliative (P) | 2015-05-15 | 2015-10-09 | A-PREDICT TRIAL | N | null | 90000280 | GEMCARBO |
| 90005353 | 90007132 | 1.23 | 52 | Palliative (P) | null | 2018-07-13 | A-PREDICT TRIAL | Y | Y | 90009583 | WT2001 |
| 90005455 | 90002844 | null | 101.8 | Palliative (P) | 2015-03-23 | 2015-03-23 | A-PREDICT TRIAL | N | N | 90017367 | EVEROLIMUS |
| 90005741 | 90002984 | 1.68 | 98.5 | Palliative (P) | null | 2016-04-01 | A-PREDICT TRIAL | null | N | 90035036 | TEMSIROLIMUS |
| 90005812 | 90003014 | 1.64 | -1 | Palliative (P) | 2015-09-03 | 2015-09-24 | A-PREDICT TRIAL | N | N | 90038563 | CISPLATIN + GEMCITABINE |
| 90005883 | 90009326 | null | 81.3 | Palliative (P) | 2016-09-27 | 2016-09-27 | A-PREDICT TRIAL | 2 | null | 90011627 | STAR TRIAL |
| 90007706 | 90008190 | 1.82 | null | Palliative (P) | 2013-08-03 | 2013-08-03 | A-PREDICT TRIAL | 01 | N | 90032431 | TRIAL |
| 20057430 | 20025186 | 1.63 | 77.8 | Neo-adjuvant (N) | 2014-06-02 | 2014-06-18 | A-PREDICT TRIAL | 01 | N | 20201993 | TRIAL |